Expertise in
3
conditions

Jong C. Jeong

Songnam, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Songnam, KR 
OverviewLocationsClinical Research

Overview

Jong Jeong practices in Songnam, Republic of Korea. Mr. Jeong is highly rated in 3 conditions, according to our data. His top areas of expertise are Chronic Kidney Disease, Lactic Acidosis, Polycystic Kidney Disease, Kidney Transplant, and Pancreas Transplant.

His clinical research consists of co-authoring 120 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Songnam, Republic of Korea
Other Locations
Seoul, Republic of Korea
Gyeonggi-do, Republic of Korea
Goyang, Republic of Korea
Suwon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Multicenter Prospective Cohort of Kidney Biopsy for Glomerular Disease Research
Multicenter Prospective Cohort of Kidney Biopsy for Glomerular Disease Research
Enrollment Status: Recruiting
Publish Date: February 12, 2020
Intervention Type: Other
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trial

120 Total Publications

Hyporesponsive fetus-specific T cell responses in multiparous human pregnancy.
Hyporesponsive fetus-specific T cell responses in multiparous human pregnancy.
Journal: Frontiers in immunology
Published: May 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jeong's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile